Mabjeesh NJ - Search Results

1

Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.

Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW, Zhong H. Mabjeesh NJ, et al. Cancer Res. 2002 May 1;62(9):2478-82. Cancer Res. 2002. PMID: 11980636

2

Nuclear expression of hypoxia-inducible factor 1alpha protein is heterogeneous in human malignant cells under normoxic conditions.

Zhong H, Mabjeesh N, Willard M, Simons J. Zhong H, et al. Cancer Lett. 2002 Jul 26;181(2):233-8. doi: 10.1016/s0304-3835(02)00053-8. Cancer Lett. 2002. PMID: 12175540

3

Gene therapy of prostate cancer: current and future directions.

Mabjeesh NJ, Zhong H, Simons JW. Mabjeesh NJ, et al. Endocr Relat Cancer. 2002 Jun;9(2):115-39. doi: 10.1677/erc.0.0090115. Endocr Relat Cancer. 2002. PMID: 12121835 Review.

4

MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.

Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ. Amir S, et al. Among authors: mabjeesh nj. Cancer Res. 2006 Jan 15;66(2):856-66. doi: 10.1158/0008-5472.CAN-05-2738. Cancer Res. 2006. PMID: 16424018

5

Dibenzoylmethane, a natural dietary compound, induces HIF-1 alpha and increases expression of VEGF.

Mabjeesh NJ, Willard MT, Harris WB, Sun HY, Wang R, Zhong H, Umbreit JN, Simons JW. Mabjeesh NJ, et al. Biochem Biophys Res Commun. 2003 Mar 28;303(1):279-86. doi: 10.1016/s0006-291x(03)00336-x. Biochem Biophys Res Commun. 2003. PMID: 12646199

6

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P. Mabjeesh NJ, et al. Cancer Cell. 2003 Apr;3(4):363-75. doi: 10.1016/s1535-6108(03)00077-1. Cancer Cell. 2003. PMID: 12726862 Free article.

7

Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.

Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H, Simons JW. Mabjeesh NJ, et al. Clin Cancer Res. 2003 Jul;9(7):2416-25. Clin Cancer Res. 2003. PMID: 12855613

8

SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.

Amir S, Wang R, Simons JW, Mabjeesh NJ. Amir S, et al. Among authors: mabjeesh nj. J Biol Chem. 2009 Apr 24;284(17):11142-51. doi: 10.1074/jbc.M808348200. Epub 2009 Feb 26. J Biol Chem. 2009. PMID: 19251694 Free PMC article.

9

HIF at the crossroads between ischemia and carcinogenesis.

Paul SA, Simons JW, Mabjeesh NJ. Paul SA, et al. Among authors: mabjeesh nj. J Cell Physiol. 2004 Jul;200(1):20-30. doi: 10.1002/jcp.10479. J Cell Physiol. 2004. PMID: 15137054 Review.

10

Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.

Amir S, Golan M, Mabjeesh NJ. Amir S, et al. Among authors: mabjeesh nj. Mol Cancer Res. 2010 May;8(5):643-52. doi: 10.1158/1541-7786.MCR-09-0497. Epub 2010 Apr 20. Mol Cancer Res. 2010. PMID: 20407014 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters